AltruBio

Drug Discovery · San Francisco, CA · Founded 2000 · Privately Held (backing)

Developer of first-in-class immune-modulators to target diseases of the immune system. AltruBio is based in San Francisco, CA and was founded in 2000. It has raised $337 million across 1 recorded round; the latest was a $225 million Series B in May 2024.

Last price · $/share
—
Implied valuation
—
Total raised
$336.6M
Last round
Later Stage VC (Series B)
May 2024
How much has AltruBio raised?
$336.6Macross 1 recorded rounds · May 2024 – May 2024

Most recently, AltruBio raised $225.0M in its Later Stage VC (Series B) (May 2024).

Free account
More of AltruBio with a free account
  • ·Watch AltruBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

AltruBio round by round

1 rounds
May 2024Later Stage VC (Series B)$225.0M▮
+ 1 more investors · free account

How much has AltruBio raised?

AltruBio has raised $337 million in total; 1 of its rounds is on record. The largest on record was a $225 million Series B in May 2024.

AltruBio investors

10 investors are on record for AltruBio, including RA Capital Management, Blackstone, Cormorant Asset Management and Soleus Capital. The Series B in May 2024 drew 7 investors.

For fundraisers
Raising for a company like AltruBio?

10 investors have backed AltruBio — start your target list with the firms already writing checks in drug discovery.

See all 10 investors →

Frequently asked about AltruBio

How much has AltruBio raised?
AltruBio has raised $336.6M in total across 1 recorded funding rounds.
When was AltruBio's last funding round?
AltruBio's most recent recorded round was Later Stage VC (Series B) in May 2024, raising $225.0M.